ProPhase Labs, Inc. (PRPH)
Sells dietary supplements and develops diagnostic tests and cancer treatment drugs.
$0.06-0.05%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-98.2%
The outlook
PRPH is trading near its 52-week low at $0.0586, well below both its 50- and 200-day moving averages. Analyst coverage appears thin or absent from the data provided. The overall sentiment leans heavily bearish based on current market positioning.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range0% of the way from its 52-week low to high
Market cap
$821,349
52-wk high
$6.70
52-wk low
$0.05
50-day avg
$0.09
200-day avg
$0.85
Trailing P/E
—